French AMF Fines US Investment Fund €10 Million for Nasdaq IPO Price Manipulation
The French Financial Markets Authority (Autorité des Marchés Financiers, AMF) Enforcement Committee has levied fines totaling €10 million against EcoR1 Capital, a San Francisco-based investment fund, and its director, Oleg Nodelman, for price manipulation during the initial public offering (IPO) of French biotech firm Innate Pharma on the Nasdaq.